LUCD - Lucid Diagnostics, Inc. P/S multiplikatori

Lucid Diagnostics, Inc (LUCD) brendining ramzi va logotipi

Shifokorlarning EsoGuard testiga bo'lgan ishonchi o'sishni ta'minlamoqda va GURU.Markets ma'lumotlari ushbu P/S koeffitsiyenti grafigiga asos bo'ladi, bunda parametr qiymati 14.60 ga tengdir. Maxsus diagnostika usullari Lucid Diagnostics Inc. (LUCD) kompaniyasini narxlar urushidan himoya qiladi, garchi Lucid Diagnostics Inc. (LUCD) kompaniyasining moliyaviy barqarorligi marketing xarajatlari va sug'urta qoplash siyosatiga bog'liq bo'lib, ular ushbu ko'rsatkichdagi savdo qiymati chegaralarini belgilaydi.

LUCD Lucid Diagnostics: P/S multiplikatori 04.07.2022 - 13.11.2026 oraligʻida

Lucid Diagnostics Inc (LUCD) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning umumiy tahlili:luciddx.com (LUCD)
Lucid Diagnostics, Inc tomonidan chiqariladigan mahsulotlar

P/S koeffitsiyenti bir dollar tushumning bozor qiymatini belgilaydi, bu esa investorga biznes uchun haddan tashqari to'lov darajasini yoki savdo hajmlariga nisbatan kapitalizatsiya o'sishi potentsialini baholash imkonini beradi. P/S grafigini tahlil qilishda, Lucid Diagnostics Inc. (LUCD) onkologik diagnostikasining noyobligi elastik bo'lmagan talabni yaratishi ta'kidlanishi kerak, bu esa sug'urta kodlarini olgach, koeffitsiyentning barqaror o'sishini ta'minlaydi va foydani inflyatsiyadan himoya qiladi.

Raqobatdosh kompaniyalar

Narxning daromadga nisbati A (agilent.com)|Quest Diagnostics Incorporated - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Illumina Inc ILMN|Cologuard - P/S multiplikatori|Revvity Corp (RVTY) - Kapitalizatsiyaning daromadga nisbati|BIO: P/S multiplikatori|NNNN - Narx/daromad koeffitsiyenti|SHC (Sotera Health) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati QDEL (Quidel Corporation)|Kapitalizatsiyaning daromadga nisbati OPK (OPKO Corp)|CDNA (CareDx Health) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori MRVI (Maravai LifeSciences)|FLGT: Kapitalizatsiya va daromad nisbati|Standard BioTools - P/S multiplikatori|Narx/daromad koeffitsiyenti Cytek Biosciences Inc CTKB|OSUR: P/S multiplikatori|Exagen (XGN) - P/S multiplikatori|MDXH (MDxHealth SA) - P/S multiplikatori|PRE - Narx/daromad multiplikatori|Narxning daromadga nisbati Insight Molecular Diagnostics (IMDX)|trinitybiotech.com - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati ProPhase PRPH|Ainos Corporation (AIMD) - Sotuvga nisbatan narx|CODX - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti heartsciences.com HSCS|BMRA (Biomerica) - Kapitalizatsiyaning daromadga nisbati|CDIO: Kapitalizatsiyaning sotish hajmiga nisbati|ONCO (Onconetix Corp) - P/S multiplikatori|Virax Biolabs Corp (VRAX) - Narx/daromad koeffitsiyenti|P/S multiplikatori BJDX|Kapitalizatsiyaning daromadga nisbati aspirawh.com AWH|Narxning daromadga nisbati Accelerate Diagnostics, Inc. AXDX|Narx/daromad koeffitsiyenti Centogene N.V. (CNTG)|ENZ: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati FRES (Fresh2 Group Limited)|GENE: P/S multiplikatori|ME - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Psychemedics Corporation